VisionChina Media Stock Soars On Strong Fundamentals (NASDAQ:VISN), Biostar Pharmaceuticals (NASDAQ:BSPM), eOn Communications (NASDAQ:EONC), Syntroleum (NASDAQ:SYNM)

VisionChina Media Inc. (NASDAQ:VISN)

As bullish positions begin to develope pushing the Dow Jones Industrial Average to 15,899.79 Up 24.53 points, we would advise you to check out VisionChina Media Inc. ticker symbol VISN. This Company’s (http://www.visionchina.cn) stock has surged +15.89% Up 2.05 generating over six hundred seventy four thousand shares in the financial markets at $14.95 per share Wednesday December 18, 2013 Real-time: 12:14PM EST. VisionChina Media Inc. operates an out-of-home advertising network on mass transportation systems, including buses and subways. The HOT topic amongst investors surrounding VisionChina Media Inc. is that its much more than a Dead Cat Bounce.

VisionChina Media Inc. posted total revenues of US$28.5 million in its Q313 financial results, a 6.9% increase when compared to its prior Q213. In addition, VisionChina Media Inc.’s gross profit was US$6.9 million in its Q313, Up US$1.8 million when compared to its prior Q213. Stock market analyst are anticipating the fresh fruit that this Company could deliver, as long as they continue to show strong signals of improvement concerning operating efficiency, and gross margin.

****

Biostar Pharmaceuticals, Inc. (NASDAQ:BSPM)

As stock market analyst estimate that the global pharmaceutical market will reach US$1.6 trillion, we would advise you to check out Biostar Pharmaceuticals, Inc. ticker symbol BSPM. This Company’s (www.biostarpharmaceuticals.com) stock has surged +7.84% Up 0.16 generating over three hundred sixty one thousand shares in the financial markets at $2.20 per share Wednesday December 18, 2013 Real-time: 12:14PM EST. Biostar Pharmaceuticals, Inc., through its wholly owned subsidiary and controlled affiliate in China, develops, manufactures and markets pharmaceutical and health supplement products for a variety of diseases and conditions. The HOT topic amongst investors surrounding Biostar Pharmaceuticals, Inc. is its Q313 revenue.

Biostar Pharmaceuticals, Inc. generated $15.01 million revenue in its Q313 financial results, Up US$5.04 million when compared to its prior Q312. The Company’s gross profit was US$6.94 million in its Q313, Up US$1.7 million when compared to its prior Q312. Biostar Pharmaceuticals, Inc. total operating expenses reduced US$4.85 million totaling $6.19 million when compared to its prior Q312. Stock market investors can’t ignore how this Company rolls. This Company operates with the highest industrial standards delivering the most highest quality products today.

Other notable stock’s that need to be mention on the wall street financial district:

eOn Communications Corporation (NASDAQ:EONC) $2.45 (+97.58%) Up 1.21 Wednesday December 18, 2013 Real-time: 12:54PM EST

Syntroleum Corp. (NASDAQ:SYNM) $3.35 (+36.18%) Up 0.89 Wednesday December 18, 2013 Real-time: 12:56PM EST

Remember: Always do your homework and consult your own financial professional.

Read Full Disclaimer at http://crweselect.com/disclaimer/